What causes high iron levels and how are they managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes and Management of High Iron Levels

Therapeutic phlebotomy is the first-line treatment for high iron levels, with a goal to reduce ferritin to 50-100 μg/L through weekly removal of 500 mL of blood. 1

Causes of High Iron Levels

Hereditary Causes

  • Hereditary Hemochromatosis (HH)
    • HFE-related: C282Y homozygosity, C282Y/H63D compound heterozygosity 2
    • Non-HFE related: Other gene mutations 2
    • Juvenile hemochromatosis 2
    • Autosomal dominant hemochromatosis 2
  • Other Rare Hereditary Disorders
    • Transferrin receptor 2 mutations (hemochromatosis type 3) 3
    • Ferroportin mutations (hemochromatosis type 4) 3
    • L-ferritin mutations causing neurodegeneration 3

Secondary Causes

  • Iron-Loading Anemias
    • Thalassemia major 2
    • Sideroblastic anemia 2
    • Chronic hemolytic anemias 2
  • Transfusional Iron Overload
    • Multiple blood transfusions for chronic anemia 4
    • Myelodysplastic syndromes requiring transfusions 2
  • Chronic Liver Diseases
    • Hepatitis B and C 2
    • Alcoholic liver disease 2
    • Fatty liver disease 2
    • Porphyria cutanea tarda 2
  • Other Causes
    • Dietary iron overload 2
    • African iron overload 2
    • Aceruloplasminemia 2
    • Congenital atransferrinemia 2

Diagnosis of Iron Overload

  1. Laboratory Testing

    • Serum ferritin (elevated >1000 ng/mL suggests significant iron overload) 1
    • Transferrin saturation (>50% for women, >60% for men) 2
    • Fasting values are preferred to avoid circadian variations 2
  2. Genetic Testing

    • HFE gene testing for C282Y and H63D mutations 5
  3. Imaging and Tissue Assessment

    • MRI for quantitative assessment of liver iron content 5
    • Liver biopsy (especially if liver disease is suspected) 5

Management of Iron Overload

Therapeutic Phlebotomy (First-Line Treatment)

  • For Hereditary Hemochromatosis and Other Primary Iron Overload Conditions
    • Remove 500 mL of blood weekly or biweekly 2, 1
    • Check hematocrit before each procedure; avoid >20% drop from previous level 2, 1
    • Monitor serum ferritin every 10-12 phlebotomies 2
    • Initial goal: Reduce ferritin to below 50 ng/mL 2
    • Maintenance: Continue phlebotomies at intervals to maintain ferritin between 25-50 ng/mL 2

Iron Chelation Therapy

  • For Secondary Iron Overload or When Phlebotomy is Contraindicated
    • Deferoxamine: 20-40 mg/kg/day 2
    • Deferasirox: For transfusional iron overload 6
    • Consider for patients with ferritin >1000 ng/mL who cannot tolerate phlebotomy 1

Special Populations

  • Myelodysplastic Syndromes

    • Consider chelation for transfusion-dependent patients requiring ≥2 units/month for >1 year 2
    • Target patients with ferritin >1000 ng/mL and low-risk MDS 2
    • Continue chelation as long as transfusions are needed 2
  • Post-Transplant Patients

    • Phlebotomy is preferred in patients with favorable prognosis >1 year after stem cell transplant 2

Monitoring and Follow-up

  • Regular monitoring of ferritin levels, liver function tests, and complete blood count 1
  • Surveillance for hepatocellular carcinoma in patients with cirrhosis 1
  • Monitor cardiac and endocrine function in severe iron overload 1

Lifestyle Modifications

  • Avoid vitamin C supplements (>500 mg/day) 2, 1
  • Limit iron-rich foods and alcohol intake 1
  • Avoid raw shellfish due to infection risk in iron-overloaded patients 1

Clinical Outcomes and Prognosis

Early diagnosis and treatment of iron overload significantly improves survival and prevents complications 2. Untreated iron overload can lead to:

  • Liver cirrhosis and hepatocellular carcinoma (30% of deaths in HH) 2
  • Cardiac dysfunction and arrhythmias 2, 1
  • Diabetes mellitus 2
  • Arthropathy 2
  • Endocrine dysfunction 2

Treatment initiated before the development of cirrhosis or diabetes can normalize life expectancy 2.

References

Guideline

Iron Overload Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rare causes of hereditary iron overload.

Seminars in hematology, 2002

Research

Iron overload disorders.

Hepatology communications, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.